Therapeutics: Lipoprotein-associated phospholipase A2 (PLA2G7; PAFAH; Lp-PLA2)

Ophthalmic disease

INDICATION: Diabetic macular edema (DME)

In vitro and rat studies identified a PLA2G7 inhibitor that could help treat DME. Chemical

Read the full 201 word article

How to gain access

Continue reading with a
two-week free trial.